scholarly journals Measurement and clinical applications of C‐reactive protein in gastrointestinal diseases of dogs

2022 ◽  
Author(s):  
Marshal A. Covin ◽  
Joerg M. Steiner
Keyword(s):  
Gastrointestinal Diseases ◽  
Clinical Applications ◽  
C Reactive Protein ◽  
Reactive Protein

scholarly journals Comparison of SARC-F Score among Gastrointestinal Diseases

2021 ◽  
Vol 10 (18) ◽  
pp. 4099
Author(s):  
Kosuke Ushiro ◽  
Hiroki Nishikawa ◽  
Masahiro Matsui ◽  
Takeshi Ogura ◽  
Toshihisa Takeuchi ◽  
...  
Keyword(s):  
Advanced Cancer ◽  
Gastrointestinal Disease ◽  
Gastrointestinal Diseases ◽  
Pancreatic Disease ◽  
Prognostic Scores ◽  
C Reactive Protein ◽  
Reactive Protein ◽  
Primary Origin ◽  
Upper Gastrointestinal ◽  
Significant Factors

SARC-F is a screening tool for sarcopenia. We sought to compare the SARC-F scores of patients with different gastrointestinal diseases (n = 1282 (762 males): upper gastrointestinal disease (UGD, n = 326), lower gastrointestinal disease (LGD, n = 357), biliary and pancreatic disease (BPD, n = 416), and liver disease (LD, n = 183)). Factors associated with SARC-F ≥4 points (highly suspicious of sarcopenia) were also examined. The median age was 71 years. Patients with SARC-F ≥4 points were found in 197 (15.4%). Advanced cancer was found in 339 patients (26.4%). The proportion of SARC-F ≥4 points in groups of UGD, LGD, BPD, and LD were 17.5% (57/326) in UGD, 12.0% (43/357) in LGD, 17.3% (72/416) in BPD, and 13.7% (25/183) in LD, respectively (overall p = 0.1235). In patients with and without advanced cancer, similar tendencies were observed. In the multivariate analysis, age (p < 0.0001), gender (p = 0.0011), serum albumin (p < 0.0001), lymphocyte count (p = 0.0019), C reactive protein (p = 0.0197), and the presence of advanced cancer (p = 0.0424) were significant factors linked to SARC-F ≥4 points. In patients with advanced cancer, SARC-F scores correlated well with their Glasgow prognostic scores. In conclusion, sarcopenia in gastrointestinal diseases may be affected not by disease type (i.e., the primary origin of the disease) but by aging, nutritional condition, inflammatory condition, and cancer burden.

scholarly journals C-reactive protein: clinical applications and proposals for a rational use

2013 ◽  
Vol 59 (1) ◽  
pp. 85-92 ◽  
Author(s):  
Francisco J.B. Aguiar ◽  
Mario Ferreira-Júnior ◽  
Maria M. Sales ◽  
Luiz M. Cruz-Neto ◽  
Luiz A.M. Fonseca ◽  
...  
Keyword(s):  
Clinical Applications ◽  
C Reactive Protein ◽  
Rational Use ◽  
Reactive Protein

Potential clinical applications of c-reactive protein

1990 ◽  
Vol 4 (3) ◽  
pp. 231-235 ◽  
Author(s):  
J. M. Okamura ◽  
J. M. Miyagi ◽  
K. Terada ◽  
Y. Hokama
Keyword(s):  
Clinical Applications ◽  
C Reactive Protein ◽  
Reactive Protein
Sign in / Sign up

Export Citation Format

Share Document